William Bonello - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Financial Officer
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 18:57:26 UTC
Previous filing
30 Dec 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +40,869 +66% $0.000000 102,742 01 Mar 2022 Direct F1
transaction NEO Common Stock Tax liability $0 -397 -0.39% $0.000000 102,345 01 Mar 2022 Direct F2
transaction NEO Common Stock Tax liability $0 -620 -0.61% $0.000000 101,725 02 Mar 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +99,772 $0.000000 99,772 01 Mar 2022 Common Stock 99,772 $21.41 Direct F9
holding NEO Stock Option (Right to Buy) 10,727 01 Mar 2022 Common Stock 10,727 $7.52 Direct F4
holding NEO Stock Option (Right to Buy) 45,370 01 Mar 2022 Common Stock 45,370 $8.03 Direct F5
holding NEO Stock Option (Right to Buy) 41,167 01 Mar 2022 Common Stock 41,167 $19.60 Direct F6
holding NEO Stock Option (Right to Buy) 37,514 01 Mar 2022 Common Stock 37,514 $28.33 Direct F7
holding NEO Stock Option (Right to Buy) 24,619 01 Mar 2022 Common Stock 24,619 $53.17 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2022, Mr. Bonello was granted 40,869 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock.
F3 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.
F4 On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F5 On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F6 On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F7 On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F8 On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F9 On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Limited Power Of Attorney